Corporate GovernanceJun 8, 2026, 04:12 PM
Climb Bio Stockholders Approve Equity Plan Amendment
AI Summary
Climb Bio, Inc. stockholders approved an amendment to the 2021 Equity Incentive Plan at the 2026 Annual Meeting, which now includes prefunded warrants in the calculation of the annual share pool increase. Additionally, Alexander (Bo) Cumbo and Douglas Williams, Ph.D., were elected to the Board of Directors for three-year terms. Stockholders also ratified PricewaterhouseCoopers LLP as the independent auditor for 2026 but did not approve an amendment to the Certificate of Incorporation regarding director removal for "cause".
Key Highlights
- Stockholders approved an amendment to the 2021 Equity Incentive Plan.
- The 2021 Plan Amendment includes prefunded warrants in the annual share pool increase calculation.
- Alexander (Bo) Cumbo and Douglas Williams, Ph.D., were elected to the Board of Directors for three-year terms.
- PricewaterhouseCoopers LLP was ratified as the independent auditor for fiscal year 2026.
- Stockholders did not approve an amendment relating to the removal of directors for "cause".
- The 2021 Plan Amendment received 19,604,493 votes for and 7,810,582 votes against.
- Alexander (Bo) Cumbo was elected with 26,035,689 votes for.
- Douglas Williams, Ph.D. was elected with 24,505,866 votes for.
Price Impact
More from CLYM
More in Corporate Governance